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Background: Home-based dialysis, including peritoneal dialysis (PD) and home hemodialysis (HHD), is associated
with improved health related quality of life and reduced health resource costs. It is uncertain to what extent initial
preferences for dialysis modality influence the first dialysis therapy actually utilized. We examined the relationship
between initial dialysis modality choice and first dialysis therapy used.
Methods: Patients with chronic kidney disease (CKD) from a single centre who started dialysis after receiving
modality education were included in this study. Multivariable logistic regression models were constructed to assess
the independent association of patient characteristics and initial dialysis modality choice with actual dialysis therapy
used and starting hemodialysis (HD) with a central venous catheter (CVC).
Results: Of 299 eligible patients, 175 (58.5%) initially chose a home-based therapy and 102 (58.3%) of these patients’
first actual dialysis was a home-based therapy. Of the 89 patients that initially chose facility-based HD, 84 (94.4%)
first actual dialysis was facility-based HD. The adjusted odds ratio (OR) for first actual dialysis as a home-based
therapy was 29.0 for patients intending to perform PD (95% confidence interval [CI] 10.7-78.8; p < 0.001) and 12.4
for patients intending to perform HHD (95% CI 3.29-46.6; p < 0.001). Amongst patients whose first actual dialysis
was HD, an initial choice of PD or not choosing a modality was associated with an increased risk of starting dialysis
with a CVC (adjusted OR 3.73, 95% CI 1.51-9.21; p = 0.004 and 4.58, 95% CI 1.53-13.7; p = 0.007, respectively).
Conclusions: Although initially choosing a home-based therapy substantially increases the probability of the first
actual dialysis being home-based, many patients who initially prefer a home-based therapy start with facility-based
HD. Programs that continually re-evaluate patient preferences and reinforce the values of home based therapies
that led to the initial preference may improve home-based therapy uptake and improve preparedness for
starting HD.
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Home-based renal dialysis therapies for end-stage renal dis-
ease (ESRD), such as peritoneal dialysis (PD), home
hemodialysis (HHD), or pre-emptive transplantation, are
associated with improved health related quality of life [1,2]
and reduced health resource costs [3]. It is widely accepted
that patients with advanced stages of chronic kidney disease
(CKD) should receive pre-ESRD modality education to en-
sure that patients able to initiate a home-based therapy
have every opportunity to do so [4].* Correspondence: brimbles@gmail.com
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reproduction in any medium, provided the orDespite the potential advantages of increased utilization
of home-based dialysis therapies, its uptake remains low in
North America [5]. The reasons for this vary, and include
late referral of patients to nephrologists, insufficient educa-
tion, lack of social supports for home therapies, and patient
comorbidities [6-11]. Others have demonstrated that
greater time spent on modality education is an independent
predictor for initiating PD as the chronic modality [9]. Ob-
servational studies also suggest that the use of multi-
disciplinary pre-dialysis clinics is associated with improved
survival [12-14]. For these reasons, guidelines recommend
timely referral of patients to a nephrologist to allow suffi-
cient time for pre-ESRD modality education and dialysis ac-
cess planning [15].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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of patients choose a home-based therapy such as PD
over facility-based hemodialysis (HD) [16,17]. However,
estimates suggest only 7%-20% of incident ESRD pa-
tients actually utilize a home-based dialysis therapy
[18-20]. Factors associated with choosing one modality
but ultimately starting on a different modality are not
well understood. To inform this issue, we studied char-
acteristics associated with initiating a home-based ther-
apy amongst patients with CKD that received pre-ESRD
modality education.
Methods
We performed a single centre, retrospective cohort
study of patient enrolled in a multi-disciplinary clinic for
CKD. This study was approved by the St. Joseph’s
Healthcare Research Ethics Board.
Study population
The Kidney Function Program at St. Joseph’s Healthcare
Hamilton, Ontario, Canada is a multi-disciplinary pre-
dialysis care program that serves an estimated popula-
tion of 1,000,000 and began in January 2004. Patients
were generally enrolled in this clinic when their serum
creatinine reached 250 μmol/L and no further diagnostic
investigations were necessary. Patients attending the
clinic between its inception date and December 2012
who had initiated dialysis for a minimum of 30 days
were included if they attended the clinic for at least
120 days, received pre-ESRD modality education, and
declared an intended dialysis modality (or explicitly de-
ferred the decision). Patients were excluded if they initi-
ated dialysis on or prior to their modality education date
or intended pre-emptive transplantation.
Modality education
The clinic staff included a nephrologist, a nurse special-
ized in CKD management, a dietician, a diabetes nurse,
and a social worker. All patients included in the study
received formal modality education from one of two
trained nurses. The education session lasted 120 minutes
and covered materials on PD, HD, HHD including noc-
turnal HD, transplantation and conservative care (i.e.,
plan to not initiate dialysis in the event of ESRD). Separ-
ate group teaching sessions were also made available to
supplement the one-on-one education. Family members
were encouraged to attend and home-based therapies
(and pre-emptive transplantation) were promoted al-
though the ultimate decision was left to the patient.
Data collection
Demographic [age, gender, diabetes mellitus (DM) status,
presence of coronary artery disease (CAD), stroke, congest-
ive heart failure (CHF), weight, and ethnicity], vascularaccess at HD initiation (central venous catheter [CVC], ar-
teriovenous fistula [AVF] or arteriovenous graft) data and
laboratory results (serum creatinine, MDRD eGFR, and al-
bumin) were prospectively collected into a local clinical
database. The dates for entry into the clinic, receipt of pre-
ESRD modality education, decision regarding intended
RRT modality, and actual RRT initiation date were pro-
spectively recorded. Reasons why PD was not chosen ini-
tially as the intended RRT a (patient or physician decision)
were also recorded. Specific reasons why patients did not
initiate PD when they originally intended to were deter-
mined retrospectively from chart review. Distances from
patient’s residence at the time of initiating RRT to the near-
est HD unit were determined using Google Maps©.
Outcomes
We evaluated the association between patient characteris-
tics, including intended dialysis modality following patient
education and actual initiated dialysis therapy. Initial dialy-
sis therapy was defined as the treatment modality at 3-
months after initiation of first ESRD therapy. Patients who
had a PD catheter inserted prior to initiating any other mo-
dality were defined as having initiated on PD regardless of
actual dialysis therapy initiated. Finally, in patients that ini-
tiated HD, we investigated the association between starting
HD with a CVC and patient characteristics including their
intended dialysis therapy.
Statistical analysis
Descriptive statistics are presented as mean (standard devi-
ation [SD]) or median (25th to 75th percentile) as appropri-
ate. Continuous and categorical variables were compared
between groups using either the one-way ANOVA or the
Pearson chi-square test, respectively for variables normally
distributed and the Kruskal-Wallis test or Mann–Whitney
U test for non-normally distributed variables. Multivariable
logistic regression models were constructed to assess the
independent association of each variable with the outcomes
described above. Independent variables were selected based
on clinical importance and plausible association with the
ability or desire to perform a dialysis modality. These vari-
ables included: intended therapy (HD, PD, HHD, undecided/
conservative), sex, age, DM, CHF, eGFR, rate of eGFR
decline in the CKD clinic, time from modality decision to
initiation of dialysis, and distance to the nearest HD unit).
To assess the predictors of starting HD with a CVC, we
restricted the sample to patients that initiated HD and
constructed a multivariable logistic regression model in
which starting with a CVC was the outcome and the inde-
pendent variables were the same as the previous model.
All potential predictors were retained in all analyses.
P-values of <0.05 for two-sided tests were considered sta-
tistically significant. All statistical analyses were performed
using IBM SPSS Statistics Version 21.
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Of 1741 patients who attended the CKD clinic, 299 pa-
tients who started dialysis after receiving modality edu-
cation met study criteria. Reasons for exclusion are
shown in Figure 1. Patients who intended to perform a
home-based therapy tended to be younger with less
CHF compared to those intending facility-based HD
(Table 1). Patients who were undecided or intended con-
servative therapy were less likely to be Caucasian and
started dialysis with a lower level of renal function com-
pared to those who intended some form of dialysis.
Compared to patients that initiated home-based dialysis,
patients who initiated facility-based HD were older, and
more commonly had CAD, CHF, and lower albumin
(Table 2). Patients who initiated on HHD took longer to
make a decision regarding their intended dialysis mo-
dality than those intending to perform facility-based HD
or PD.
One hundred seventy-five patients (54.3%, 154 PD and
21 HHD) intended to initiate a home-based therapy
(Table 3). Ninety-one of the 154 patients (59.1%) who
intended to perform PD actually did so; similar propor-
tions were seen for those intending to initiate HHD.
Overall, 102 of 175 (58.3%) participants planning to ini-
tiate home-based dialysis actually did so. This is in con-
trast to 84 of 89 (94.4%) patients intending to initiate
facility-based HD and who went on to do so. Similarly,
33 of 35 (94.3%) patients that intended conservative
therapy or deferred a decision went on to initiate
facility-based HD.
The independent associations with performing a
home-based therapy are shown in Table 4. Compared to
choosing facility-based HD, intending to perform a
home-based therapy (PD or HHD) was strongly associ-
ated with initiating PD or HHD (adjusted OR 29.0 [95%
CI 10.7-78.8] and 12.4 [95% CI 3.29-46.6], respectively;Figure 1 Study population selection.p < 0.001). The presence of CHF was a negative pre-
dictor of starting a home-based therapy (OR 0.25 [95%
CI 0.11-0.58]; p < 0.001) whereas age, sex and DM were
not. Factors which would be associated with more time
to plan a home-based therapy, namely increased avail-
able time and a slower rate of loss of eGFR, were not in-
dependently associated with initiating a home-based
dialysis therapy. Interestingly, a longer period of time
from modality decision to initiation was associated with
a decreased odds of starting a home therapy (OR 0.67
[95% CI 0.50-0.89]; p = 0.006).
Of the 197 total patients that initiated on HD (facility-
based or HHD), 128 (65.0%) did so with a CVC. Table 3
shows the multivariable associations with initiating HD
using a CVC. Female sex and increased age were associ-
ated with a CVC as the initial vascular access. Intending
to perform PD was also associated with an increased
probability of using a CVC (OR 3.73 [95% CI 1.51-9.21];
p = 0.004). Similarly, being undecided or intending con-
servative therapy was associated with an increased
chance of ultimately initiating HD with a CVC as the
initial vascular access (OR 4.58 [95% CI 1.53-13.7]; p =
0.007). Having more time between modality decision
and initiation of dialysis was associated with a decreased
probability of starting HD with a CVC (OR 0.70 [95% CI
0.51-0.95; p = 0.024).
Reasons why patients did not initiate on PD are out-
lined in Table 5. In patients initially intending to per-
form PD, 36.5% did not perform PD because of an
earlier than anticipated requirement for dialsyis and
36.5% changed their mind, almost exclusively because of
a preference for a hospital-based therapy.
Discussion
We demonstrated that patients who intend a home-
based dialysis therapy still frequently initiate facility-
Table 1 Patient characteristics based on intended renal replacement modality
Variable HD (89) HHD (21) PD (154) Conservative/undecided (35) Total (299) P value
Age, years (SD) 72.1 (11.2) 63.1 (10.1) 68.2 (12.9) 69.5 (12.9) 69.1 (12.4) 0.012
Males, n (%) 59 (66.3) 15 (71.4) 82 (53.2) 22 (62.9) 178 (59.5) 0.13
Diabetes mellitus, n (%) 59 (66.3) 11 (52.4) 95 (61.7) 20 (57.1) 185 (61.9) 0.60
Coronary artery disease, n (%) 40 (45.5) 8 (38.1) 55 (36.9) 12 (35.3) 115 (39.4) 0.58
Previous stroke, n (%) 20 (23.0) 1 (4.8) 24 (15.8) 8 (22.9) 53 (18.0) 0.17
Congestive heart failure, n (%) 30 (34.5) 3 (14.3) 28 (18.4) 11 (31.4) 72 (24.4) 0.02
Weight, kg (SD) 85.7 (19.2) 98.2 (31.7) 84.7 (19.2) 84.4 (20.7) 85.9 (21.0) 0.048
Ethnicity, n (%)
Caucasian 80 (89.9) 19 (90.5) 133 (86.4) 22 (62.9) 254 (84.9)
Afro-Canadian 4 (4.5) 0 (0) 8 (5.2) 5 (14.3) 17 (5.7) 0.007
Aboriginal 2 (2.2) 2 (9.5) 2 (1.3) 3 (8.6) 9 (3.0)
Other 3 (3.4) 0 (0) 11 (7.1) 5 (14.3) 19 (6.4)
Creatinine, μmol/L (IQR)a 512.0 (405.0, 633.0) 535.0 (441.0, 662.5) 459.0 (418.0, 562.0) 622.0 (489.0, 783.0) 500.0 (418.0, 629.0) 0.001
eGFR, ml/min/1.73 m2 (SD) 9.4 (3.4) 10.1 (5.2) 9.6 (3.0) 7.7 (3.6) 9.4 (3.4) 0.022
Albumin, g/L (SD) 35.2 (5.3) 36.1 (6.4) 36.4 (4.5) 34.4 (4.0) 35.9 (5.0) 0.092
eGFR decrease,
ml/min/1.73 m2/year (IQR)a,b 3.4 (1.6, 5.8) 3.6 (1.9, 7.5) 3.5 (2.2, 5.3) 4.0 (2.0, 7.3) 3.5 (1.9, 5.6) 0.83
Time- entry to decision, days (IQR)a 162.0 (85.0, 411.5) 128.0 (50.5, 369.5) 109.0 (40.5, 223.0) 157.0 (48.0, 379.0) 127.0 (49.0, 273.0) 0.010
Time-decision to initiation, days (IQR)a 334.0 (137.5, 618.0) 322.0 (145.5, 855.0) 325.5 (148.8, 325.5) 241.0 (66.0, 797.0) 323.0 (141.0, 731.0) 0.62
Distance to nearest HD unit, km (IQR)a 4.6 (2.2, 8.5) 5.5 (3.6, 10.7) 5.9 (3.0, 10.3) 6.4 (2.4, 10.9) 5.5 (2.6, 9.4) 0.22
Note: Means and standard deviations shown for normally distributed variables. Median and interquartile range values indicated by (a) for non-normally distributed variables. bchange in eGFR multiplied by (−1) based
on available values preceding dialysis initiation.


















Table 2 Patient characteristics based on first renal replacement modality initiated
Variable HD (190) HHD (14) PD (95) Total (299) P value
Age, years (SD) 70.3 (11.6) 61.9 (10.7) 67.9 (13.8) 69.1 (12.4) 0.024
Males, n (%) 119 (62.6) 11 (78.6) 48 (50.5) 178 (59.5) 0.048
Diabetes mellitus, n (%) 120 (63.2) 9 (64.3) 56 (58.9) 185 (61.9) 0.77
Coronary artery disease, n (%) 83 (45.4) 3 (21.4) 29 (30.5) 115 (39.4) 0.021
Previous stroke, n (%) 39 (21.0) 0 (0) 14 (14.7) 53 (18.0) 0.087
Congestive heart failure, n (%) 61 (32.8) 0 (0) 11 (11.6) 72 (24.4) <0.001
Weight, kg (SD) 87.1 (21.1) 97.5 (30.6) 82.0 (18.1) 85.9 (21.0) 0.017
Ethnicity, n (%)
Caucasian 161 (84.7) 12 (85.7) 81 (85.3) 254 (84.9)
Afro-Canadian 13 (6.8) 0 (0) 4 (4.2) 17 (5.7) 0.72
Aboriginal 6 (3.2) 1 (7.1) 2 (2.1) 9 (3.0)
Other 10 (5.3) 1 (7.1) 8 (8.4) 19 (6.4)
Creatinine, μmol/L (IQR)a 524.5 (431.8, 524.5) 624.5 (486.0, 733.5) 446.0 (398.0, 532.0) 500.0 (418.0, 629.0) <0.001
eGFR, ml/min/1.73 m2 (SD) 9.2 (3.6) 8.3 (3.2) 9.9 (3.0) 9.4 (3.4) 0.10
Albumin, g/L (SD) 35.2 (4.9) 37.5 (6.2) 36.8 (4.5) 35.9 (5.0) 0.013
eGFR decrease,
ml/min/1.73 m2/year (IQR)a,b 3.2 (1.7, 5.5) 5.1 (2.7, 7.4) 3.7 (2.3, 5.4) 3.5 (1.9, 5.6) 0.056
Time- Entry to decision, days (IQR)a 147.5 (65.0, 359.3) 241.0 (42.5, 449.0) 108.0 (39.0, 190.0) 127.0 (49.0, 273.0) 0.011
Time-Decision to initiation, days (IQR)a 391.0 (139.0, 797.3) 436.0 (135.3, 589.0) 265.0 (146.0, 519.0) 323.0 (141.0, 731.0) 0.38
Distance to nearest HD unit, km (IQR)a 5.2 (2.5, 9.0) 5.6 (3.8, 16.5) 6.1 (3.0, 12.6) 5.5 (2.6, 9.4) 0.35
Note: Means and standard deviations shown for normally distributed variables. Median and interquartile range values indicated by (a) for non-normally distributed
variables. bchange in eGFR multiplied by (−1) based on available values preceding dialysis initiation.
Abbreviations: HD hemodialysis, HHD home hemodialysis, PD peritoneal dialysis, kg kilograms, eGFR estimated glomerular filtration rate based on 4-variable MDRD
equation, km kilometers.
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CVC as their initial vascular access. These results under-
score the importance of the initial consideration of
home-based dialysis therapies but also the need to con-
tinually re-evaluate and reinforce modality choices to
improve preparedness for HD.
Utilization of home-based dialysis, including PD and
HHD, remains low in North America [5]. Reasons for this
are varied, however lack of appropriate pre-ESRD modality
education [21,22] and/or late referral to a nephrologist [11]
have often been suggested as reasons for high rates ofTable 3 Distribution of patient numbers based on intended a
Actual
PD HHD






Notes: P value < 0.001.
Abbreviations: ESRD end-stage renal disease, PD peritoneal dialysis, HHD home hemutilization of facility-based HD. In our study, all patients
were followed for at least 120 days and they received stan-
dardized, pre-ESRD modality education by a trained nurse.
Despite this, home-based dialysis was the first actual mo-
dality in a minority of patients with many abandoning an
initial preference for a home-based therapy. This suggests
factors other than availability of pre-ESRD modality educa-
tion and timing of referral influence the frequency with
which patients utilize home-based dialysis.
Very few studies systematically evaluated the relation-
ship between intended and first actual initiated dialysisnd actual ESRD therapies initiated









Table 4 Multivariable logistic regression analysis of factors associated with home-based dialysis initiation and HD
initiation using a catheter
Outcome Home-based RRT start Start HD with a CVC
N = 299 N = 197
Variable Odds ratio [95% CI] p-value Odds ratio [95% CI] p-value
Intended modalitya
HD Referent Referent
PD 29.0 (10.7, 78.8) <0.001 3.73 (1.51, 9.21) 0.004
HHD 12.4 (3.29, 46.6) <0.001 0.72 (0.23, 2.22) 0.56
Undecided/conservative 0.95 (0.17, 5.32) 0.96 4.58 (1.53, 13.7) 0.007
Age, per 10-years 0.92 (0.71, 1.18) 0.50 1.59 (1.15, 2.21) 0.006
Female sex 0.91 (0.48, 1.73) 0.78 3.24 (1.46, 7.20) 0.004
Diabetes mellitus 0.99 (0.51, 1.91) 0.97 1.57 (0.73, 3.39) 0.25
Congestive heart failure 0.25 (0.11, 0.58) <0.001 3.74 (1.56, 8.96) 0.003
Weight, per 10-kg 0.94 (0.80, 1.09) 0.40 1.10 (0.92, 1.32) 0.29
eGFR decrease, per 1-ml/min/1.73 m2/yrb 0.99 (0.92, 1.07) 0.88 1.09 (0.99, 1.21) 0.093
Time-decision-initiation, years 0.67 (0.50, 0.89) 0.006 0.70 (0.51, 0.95) 0.024
Notes: areference group is HD. bchange in eGFR multiplied by (−1).
Abbreviations: RRT renal replacement therapy, CVC central venous catheter, SE standard error, PD peritoneal dialysis, HHD home hemodialysis, kg kilogram,
ml milliliter, m meters, eGFR estimated glomerular filtration rate based on 4-variable MDRD equation, yr year.
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mismatch. A study by Liebman et al [23]. evaluated 217
patients who had received ESRD modality education at a
single U.S. centre and went on to start dialysis. More
than half of the patients selected PD as their initial
choice modality but less than half of these ultimately ini-
tiated PD. A second study [24] found that an even
higher proportion of patients than observed in the
present study did not declare an intended therapy after
modality education (49%). These studies were limited byTable 5 Reasons provided for patients not performing PD
who intended to initiate PD
Reason patient did not start on PD N (%)
Medical reasons 38 (60.3)
Acute start 23 (36.5)
Abdominal surgeries 5 (7.9)
Hernia 2 (3.2)
Obesity 2 (3.2)
Cognitive impairment 1 (1.6)
Abdominal aortic aneurysm 2 (3.2)
Shunt 1 (1.6)
Stroke 1 (1.6)
Patient in nursing home 1 (1.6)
Patient reasons 24 (38.1)
Patient preference for hospital-based treatment 23 (36.5)
Lack of space in home 1 (1.6)
Unknown 1 (1.6)either smaller sample size or incomplete data, however
their broad similarity to the findings in our study are
encouraging.
The reasons for abandoning the initial choice to perform
a home-based therapy, particularly PD, are multiple.
Amongst patients that intended to do PD but did not, more
than 60% were for medical reasons. Although the majority
of these were relative rather than absolute contraindica-
tions, they were perhaps the final contributor to the deci-
sion making process. Additionally, a preference change
accounted for over one-third of those who did not initiate
on PD as intended in this cohort. In our study we focused
on patient’s medical characteristics to explain changes in
preference. However, these characteristics explained very
little of why patients who initially chose a home-based ther-
apy did not start a home based therapy. More information
on the psycho-social, environmental and logistical chal-
lenges that may contribute to why patients change their
preference for home-based therapies is needed. A change
in the patient’s perceived ability to perform PD between the
time of initial modality decision and dialysis initiation may
be partially responsible for the preference change and is
consistent with the finding that an increase in this time
interval was associated with reduced odds of starting a
home-based therapy such as PD. Additionally, about one
third of patients required dialysis earlier than first antici-
pated, leading to initiation of facility-based HD despite a
declared intent to perform a home-based therapy. More
careful planning of the timing of PD catheter insertion, the
use of embedded PD catheters, or the availability of urgent
PD catheter insertions may mitigate this issue.
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but started on a different modality was not available. The
increased need for home resources associated with HHD
(e.g. costs of home utilities and suitable water supply) may
have played a role in the modality initiated. Further efforts
are required to understand if the medical and non-medical
events that alter patient preferences can be avoided and/or
their effect on modality choice mitigated.
Changes in modality choice (i.e. patients initially un-
decided, wanted conservative care or wanted PD and ultim-
ately started HD) resulted in a three to four-fold increase in
the risk of initiating HD with a CVC. This risk could not be
attributed to non-function of a PD catheter as such patients
were counted as a PD start for the purposes of this analysis.
Therefore, these results support the need for reinforcing
and re-evaluating a patient’s modality decision over time.
This suggests changes in decisions about dialysis modality
late in the progression of CKD, particularly when unantici-
pated, may result in facility-based HD starts that may
be suboptimal (e.g. initiating HD with a CVC rather than
an AVF).
The finding that the presence of CHF was associated with
decreased likelihood of starting a home-based therapy was
somewhat unexpected. Previously published data indicating
that the presence of CHF is associated with worse out-
comes in PD patients as compared to HD [25] may have
tempered nephrologists’ enthusiasm for PD in such pa-
tients, and directed this population towards HD. Alterna-
tively, CHF may simply have been a marker of poor
functional status and therefore less ability to ultimately per-
form a home-based therapy.
There are several limitations of this study. This is a
single centre study which may limit generalizability to
centres with different educational programs, patient
mixes, and access to facility or home-based therapies.
Despite this, the proportion of our patients that declared
an initial intention to perform a home-based dialysis
therapy and the proportion that actually initiated a
home-based therapy are similar to those reported by
other centres. Also, our study was retrospective with the
inherent possibility to introduce bias in data collection.
Much of the data, however, was collected prospectively
and follow-up of patients was complete. As an observa-
tional study, our results are prone to residual confounding
particularly as the determinants of initiating a home-based
therapy are not certain from existing literature. For ex-
ample, information regarding patients’ social supports
and socioeconomic status may be relevant but was not
available for our study [10].
Conclusions
In conclusion, this study demonstrates there is a high
probability that patients that intend to perform a home-
based dialysis therapy, such as PD or HHD, are muchless likely to initiate a home-based therapy compared to
patients intending to perform facility-based HD. Add-
itionally, these patients are disadvantaged by being more
likely to start HD with a CVC rather than an AVF or ar-
teriovenous graft. This study highlights the need for fur-
ther research to better characterize time-dependent
barriers to initiating home-based therapies and to de-
velop interventions which will reduce these barriers. Pa-
tients who initially are appropriate for PD and prefer
this modality, but have a change in their psychosocial or
medical status that ultimately precludes performing PD
at home, would be better served by earlier identification
of this change leading to an improvement in vascular ac-
cess planning.
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